Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Condition:   Seborrheic Dermatitis Intervention:   Drug: ARQ-154 foam or ARQ-154 vehicle Sponsor:   Arcutis, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials